Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial

1. Puig, N.
2. Agulló, C.
3. Contreras, T.
4. Pérez, J.-J.
5. Aires, I.
6. Calasanz, M.-J.
7. García-Sanz, R.
8. Castro, S.
9. Martínez-López, J.
10. Rodríguez-Otero, P.
11. González-Calle, V.
12. González, M.S.
13. Oriol, A.
14. Gutiérrez, N.C.
15. Ríos-Tamayo, R.
16. Rosiñol, L.
17. Álvarez, M.-Á.
18. Bargay, J.
19. González-Rodríguez, A.-P.
20. Alegre, A.
21. Escalante, F.
22. Iñigo, M.-B.
23. de la Rubia, J.
24. Teruel, A.-I.
25. de Arriba, F.
26. Palomera, L.
27. Hernández, M.T.
28. López-Jiménez, J.
29. Reinoso, M.
30. García-Mateo, A.
31. Ocio, E.M.
32. Bladé, J.
33. Lahuerta, J.-J.
34. Cedena, M.-T.
35. Paiva, B.
36. San Miguel, J.F.
37. Mateos, M.-V.
38. Show all authors +

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3324/HAEMATOL.2024.285742 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus